盐酸曲普利啶结构式
|
常用名 | 盐酸曲普利啶 | 英文名 | Triprolidine hydrochloride |
---|---|---|---|---|
CAS号 | 6138-79-0 | 分子量 | 314.85200 | |
密度 | N/A | 沸点 | 462ºC at 760 mmHg | |
分子式 | C19H25ClN2O | 熔点 | 115-120ºC | |
MSDS | 中文版 美版 | 闪点 | 233.2ºC | |
符号 |
GHS07 |
信号词 | Warning |
盐酸曲普利啶用途盐酸曲普利啶是一种口服活性、细胞渗透性和第一代组胺H1拮抗剂[1]。盐酸曲普利啶是一种抗组胺药,可用于过敏性鼻炎、哮喘和荨麻疹[2]。 |
中文名 | 盐酸曲普利啶 |
---|---|
英文名 | triprolidine hydrochloride monohydrate |
英文别名 | 更多 |
描述 | 盐酸曲普利啶是一种口服活性、细胞渗透性和第一代组胺H1拮抗剂[1]。盐酸曲普利啶是一种抗组胺药,可用于过敏性鼻炎、哮喘和荨麻疹[2]。 |
---|---|
相关类别 | |
靶点 |
H1 Receptor |
体内研究 | 曲普利啶(间隔内注射;0.5μl中0.5μM;破伤风后30、60和180 min)对基线fEPSPs没有显著影响,但是,与盐水注射(60 min时为208%)相比,步行时诱导的长时程增强(LTP)较小(60 min时为基线值的173%)[2]。动物模型:成年雄性Long-Evans TMN(tuberomamillary nucleus,TMN)损伤大鼠[2]剂量:0.5μl给药0.5μm:间隔内灌注;破伤风后30、60、180min结果:LTP的步行相关增强减弱。 |
参考文献 |
沸点 | 462ºC at 760 mmHg |
---|---|
熔点 | 115-120ºC |
分子式 | C19H25ClN2O |
分子量 | 314.85200 |
闪点 | 233.2ºC |
精确质量 | 314.15500 |
PSA | 16.13000 |
LogP | 4.65740 |
外观性状 | 白色结晶粉末 |
储存条件 | 2-8°C |
稳定性 | Stable, but discolours in light. Incompatible with strong oxidizing agents. |
水溶解性 | >=10 g/100 mL at 20 ºC |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H302-H315-H319-H335 |
警示性声明 | P301 + P312 + P330-P305 + P351 + P338 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xn:Harmful; |
风险声明 (欧洲) | R22;R36/37/38 |
安全声明 (欧洲) | S26-S36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | UT7658000 |
Involvement of histaminergic inputs in the jaw-closing reflex arc.
J. Neurophysiol. 113 , 3720-35, (2015) Histamine receptors are densely expressed in the mesencephalic trigeminal nucleus (MesV) and trigeminal motor nucleus. However, little is known about the functional roles of neuronal histamine in cont... |
|
Development and validation of an ultra-performance liquid chromatography method for simultaneous analysis of 20 antihistaminics in dietary supplements.
Biomed. Chromatogr. 29(3) , 465-74, (2015) The purpose of this study was to develop and validate an ultra-performance liquid chromatography method for simultaneous analysis of 20 antihistamines (illegal additives) in dietary supplements. The l... |
|
Quantification of antihistamine acrivastine in plasma by solid-phase extraction and high-performance liquid chromatography.
J. Pharm. Biomed. Anal. 43(1) , 293-7, (2007) An automated solid-phase extraction method was developed for the determination of the H1-antihistamine acrivastine in plasma samples. Acrivastine was analyzed at the wavelength of 254 nm using a rever... |
MFCD00150574 |
Triprolidine hydrochloride |